Cytotoxic Engineered Induced Neural Stem Cells as an Intravenous Therapy for Primary Non–Small Cell Lung Cancer and Triple-Negative Breast Cancer
Alison R. Mercer-Smith(University of North Carolina at Chapel Hill), Shawn Hingtgen(University of North Carolina at Chapel Hill), Wulin Jiang(University of North Carolina at Chapel Hill), Alex S. Woodell(Medical University of South Carolina), Morrent Thang(University of North Carolina at Chapel Hill), Alain Valdivia(University of Havana), Juli R. Bagó(University of Ostrava), Stephanie A. Montgomery(University of North Carolina at Chapel Hill), Kevin Sheets(University of North Carolina at Chapel Hill), Carey K. Anders(Duke University)
Cited by 4
Related Papers
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
|New England Journal of Medicine|2019|1.3k
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice
|Science Translational Medicine|2020|1.2k
Brain metastases
|Nature Reviews Disease Primers|2019|1.1k
Young Age at Diagnosis Correlates With Worse Prognosis and Defines a Subset of Breast Cancers With Shared Patterns of Gene Expression
|Journal of Clinical Oncology|2008|917